These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18937625)

  • 1. Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes.
    Irwin N; McClean PL; Patterson S; Hunter K; Flatt PR
    Biol Chem; 2009 Jan; 390(1):75-80. PubMed ID: 18937625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the long-term effects of gastric inhibitory polypeptide-ovalbumin conjugates on insulin resistance, metabolic dysfunction, energy balance and cognition in high-fat-fed mice.
    Irwin N; Montgomery IA; Flatt PR
    Br J Nutr; 2012 Jul; 108(1):46-56. PubMed ID: 22260799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity and antidiabetic potential of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide, GIP(1-16) and (Pro3)GIP(1-16).
    Irwin N; Green BD; Parker JC; Gault VA; O'Harte FP; Flatt PR
    Regul Pept; 2006 Jul; 135(1-2):45-53. PubMed ID: 16675042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active immunization against (Pro(3))GIP improves metabolic status in high-fat-fed mice.
    Montgomery IA; Irwin N; Flatt PR
    Diabetes Obes Metab; 2010 Sep; 12(9):744-51. PubMed ID: 20649625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice.
    Irwin N; McClean PL; Flatt PR
    J Pept Sci; 2007 Jun; 13(6):400-5. PubMed ID: 17486662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide.
    Irwin N; Clarke GC; Green BD; Greer B; Harriott P; Gault VA; O'Harte FP; Flatt PR
    Biochem Pharmacol; 2006 Sep; 72(6):719-28. PubMed ID: 16859646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties.
    Kerr BD; Irwin N; O'Harte FP; Bailey CJ; Flatt PR; Gault VA
    Biochem Pharmacol; 2009 Oct; 78(8):1008-16. PubMed ID: 19523458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
    Irwin N; McClean PL; O'Harte FP; Gault VA; Harriott P; Flatt PR
    Diabetologia; 2007 Jul; 50(7):1532-40. PubMed ID: 17486314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric inhibitory polypeptide and the entero-insular axis in streptozotocin diabetic mice.
    Bailey CJ; Flatt PR; Kwasowski P; Adams M
    Diabete Metab; 1986 Dec; 12(6):351-4. PubMed ID: 3545933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice.
    Pathak V; Gault VA; Flatt PR; Irwin N
    Mol Cell Endocrinol; 2015 Feb; 401():120-9. PubMed ID: 25449420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss.
    Jones IR; Owens DR; Luzio SD; Hayes TM
    Diabete Metab; 1989; 15(1):11-22. PubMed ID: 2721810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats.
    Irwin N; Francis JM; Flatt PR
    Biol Chem; 2011 Oct; 392(10):909-18. PubMed ID: 21851286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable agonist of glucose-dependent insulinotropic polypeptide (GIP) restores pancreatic beta cell glucose responsiveness but not glucose intolerance in aging mice.
    Irwin N; Green BD; Gault VA; Harriot P; O'Harte FP; Flatt PR
    Exp Gerontol; 2006 Feb; 41(2):151-6. PubMed ID: 16378704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice.
    Green BD; Irwin N; Cassidy RS; Gault VA; Flatt PR
    Peptides; 2006 Sep; 27(9):2343-9. PubMed ID: 16730098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of glucose-dependent insulinotropic polypeptide (GIP) during cold acclimation.
    Irwin N; Francis JM; Flatt PR
    Regul Pept; 2011 Feb; 167(1):91-6. PubMed ID: 21146561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
    Taylor A; Irwin N; McKillop AM; Flatt PR; Gault VA
    Biol Chem; 2008 Apr; 389(4):441-5. PubMed ID: 18225986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy.
    McClean PL; Irwin N; Hunter K; Gault VA; Flatt PR
    Br J Pharmacol; 2008 Nov; 155(5):690-701. PubMed ID: 18695644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37).
    Irwin N; Gault VA; Green BD; Greer B; Harriott P; Bailey CJ; Flatt PR; O'Harte FP
    Biol Chem; 2005 Jul; 386(7):679-87. PubMed ID: 16207089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of sub-chronic ablation of the incretin receptors by daily administration of (Pro3)GIP and exendin(9-39)amide in obese diabetic (ob/ob) mice.
    Parker JC; Irwin N; Lavery KS; Green BD; O'Harte FP; Gault VA; Flatt PR
    Biol Chem; 2007 Feb; 388(2):221-6. PubMed ID: 17261085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in
    Shimazu-Kuwahara S; Harada N; Yamane S; Joo E; Sankoda A; Kieffer TJ; Inagaki N
    Mol Metab; 2017 Mar; 6(3):288-294. PubMed ID: 28271035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.